Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study

Knowledge of the effectiveness of cardioprotective medication in women with suspected ischemia is hampered by limited clinical trial data and heterogeneous risk. We assessed the effectiveness of cardioprotective medical treatment in women while adjusting for disease severity determined by cardiovascular magnetic resonance imaging (CMRI).